Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Marimed (MRMD) Non-Current Receivables (2016 - 2025)

Marimed (MRMD) has disclosed Non-Current Receivables for 11 consecutive years, with $814000.0 as the latest value for Q1 2025.

  • On a quarterly basis, Non-Current Receivables changed 0.0% to $814000.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $814000.0, a 0.0% change, with the full-year FY2024 number at $840000.0, up 33.33% from a year prior.
  • Non-Current Receivables was $814000.0 for Q1 2025 at Marimed, down from $840000.0 in the prior quarter.
  • In the past five years, Non-Current Receivables ranged from a high of $8.5 million in Q2 2023 to a low of $593000.0 in Q2 2024.
  • A 5-year average of $1.8 million and a median of $814000.0 in 2024 define the central range for Non-Current Receivables.
  • Peak YoY movement for Non-Current Receivables: surged 1047.49% in 2023, then tumbled 92.99% in 2024.
  • Marimed's Non-Current Receivables stood at $1.7 million in 2021, then soared by 344.99% to $7.5 million in 2022, then tumbled by 91.56% to $630000.0 in 2023, then skyrocketed by 33.33% to $840000.0 in 2024, then dropped by 3.1% to $814000.0 in 2025.
  • Per Business Quant, the three most recent readings for MRMD's Non-Current Receivables are $814000.0 (Q1 2025), $840000.0 (Q4 2024), and $814000.0 (Q3 2024).